schizophrenia

Self-care, education and anti-craving treatment predict better quality of life in dual diagnosis more than drinking scores.

Trying long-acting antipsychotic injections first-hand makes schizophrenia patients far more willing to continue using them.

New research suggests clozapine blood monitoring could safely shift from weekly to monthly checks after just 18 weeks.

Family carers manage schizophrenia by focusing on long-term stability, balancing independence with relapse prevention through daily home support.

Trust in mental health recovery grows through consistent, patient presence, not clinical technique.

Inaccurate media coverage fuels harmful mental health stigma, meaning responsible reporting is essential to encourage people towards seeking help.

A short VR tree experience reduced symptoms in patients with depression and schizophrenia in a new clinical study.

Several treatments show promise for treatment-resistant schizophrenia when clozapine is unsuitable, but stronger evidence is still needed.

A major review finds no biomarker yet predicts psychosis reliably enough for routine clinical use.

A major Irish study finds that familiarity, not knowledge, reduces schizophrenia stigma most effectively.

A single gene variant in one family caused schizophrenia, catatonia, and intellectual disability across three individuals.

Dopamine and opioids manage the body’s energy budget, making pleasure a byproduct of metabolic efficiency.

Brain scans reveal shared white matter changes in schizophrenia and bipolar disorder, supporting a psychosis spectrum and potentially improving earlier diagnosis.

Case management coordinates housing, healthcare, and daily support, helping people with schizophrenia maintain stability and reduce hospitalisation risk.